Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up

Marie Dvorakova1, Rajiv Dhir2, Sheldon Bastacky2, Kathleen Cieply3, Marie Acquafondata2, Carol R Sherer3, Tracy L Mercuri3, Anil V. Parwani2
1Department of Pathology, UPMC Presbyterian, 3550 Terrace Street, Pittsburgh, PA, 15261, USA
2Department of Pathology, UPMC Shadyside, 5230 Centre Avenue, Pittsburgh, PA, 15232, USA
3Insitu Laboratory, UPMC Montefiore, 3459 Fifth Avenue, Pittsburgh, PA, 15213, USA

Tóm tắt

Abstract Clinical studies have confirmed that renal oncocytoma (RO) is a benign neoplasm with excellent prognosis. In diagnostically challenging cases of renal oncocytic epithelial neoplasms, fluorescent in-situ hybridization (FISH) is increasingly being used and its ability to distinguish RO from chromophobe renal cell carcinoma (ChRCC) has been documented. In this study, we evaluated the differential diagnostic contribution of FISH in cases of RO. Clinicopathologic data and glass slides from 73 patients with RO were reviewed; 20 cases of ChRCC were included for comparison. FISH analysis of formalin-fixed, paraffin-embedded sections was performed using centromeric probes for chromosomes 1, 2, 7 and 17. FISH analysis revealed ROs had frequent loss of signal for chromosome 1 (56%) and 17 (44%). Tumors with more than one loss were common (41%) and 10% cases showed loss of all chromosomes examined. A total of 18% cases did not show any abnormality. Our study shows that chromosomal abnormalities in both ROs and ChRCCs are common with frequent loss of chromosomes 1 and 17. No association was found between overall patient survival and the extent of chromosomal abnormalities. FISH results, even those showing significant chromosomal abnormalities, should not alter the primarily morphology-based diagnosis of RO.

Từ khóa


Tài liệu tham khảo

Reuter VE, Davis CJ, Moch H: Oncocytoma. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. World Health Classification of Tumours. 2004, Lyon, France: IARC Press, 6: 9-87.

Amin MB, Crotty TB, Tickoo SK, Farrow GM: Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. [see comment][erratum appears in Am J Surg Pathol 1997 Jun;21(6):742]. Am J Surg Pathol. 1997, 21 (1): 1-12. 10.1097/00000478-199701000-00001.

Perez-Ordonez B, Hamed G, Campbell S: Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol. 1997, 21 (8): 871-83. 10.1097/00000478-199708000-00001.

Tickoo SK, Amin MB: Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. Am J Clin Pathol. 1998, 110 (6): 782-7.

Tickoo SK, Lee MW, Eble JN: Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol. 2000, 24 (9): 1247-56. 10.1097/00000478-200009000-00008.

Young AN, Amin MB, Moreno CS: Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. [erratum appears in Am J Pathol 2002 Jun;160(6):2311]. Am J Pathol. 2001, 158 (5): 1639-51.

Schuetz AN, Yin-Goen Q, Amin MB: Molecular classification of renal tumors by gene expression profiling. J Mol Diagn. 2005, 7 (2): 206-18.

Akhtar M, Tulbah A, Kardar AH, Ali MA: Sarcomatoid renal cell carcinoma: the chromophobe connection. Am J Surg Pathol. 1997, 21 (10): 1188-95. 10.1097/00000478-199710000-00009.

de Peralta-Venturina M, Moch H, Amin M: Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 2001, 25 (3): 275-84. 10.1097/00000478-200103000-00001.

Fuzesi L, Frank D, Nguyen C, Ringert RH, Bartels H, Gunawan B: Losses of 1p and chromosome 14 in renal oncocytomas. Cancer Genet Cytogenet. 2005, 160 (2): 120-5. 10.1016/j.cancergencyto.2004.12.010.

Brown JA, Takahashi S, Alcaraz A: Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. [see comment]. J Urol. 1996, 156 (1): 31-5. 10.1016/S0022-5347(01)65929-9.

Brunelli M, Eble JN, Zhang S, Martignoni G, Delahunt B, Cheng L: Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol. 2005, 18 (2): 161-9. 10.1038/modpathol.3800286.

Paner GP, Lindgren V, Jacobson K: High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies. Arch Pathol Lab Med. 2007, 131 (1): 81-5.

Thrash-Bingham CA, Salazar H, Greenberg RE, Tartof KD: Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor supressor gene for renal oncocytomas. Genes Chromosomes Cancer. 1996, 16 (1): 64-7. 10.1002/(SICI)1098-2264(199605)16:1<64::AID-GCC9>3.0.CO;2-1.

Iqbal MA, Akhtar M, Ulmer C, Al-Dayel F, Paterson MC: FISH analysis in chromophobe renal-cell carcinoma. Diagn Cytopathol. 2000, 22 (1): 3-6. 10.1002/(SICI)1097-0339(200001)22:1<3::AID-DC2>3.0.CO;2-0.

Speicher MR, Schoell B, du Manoir S: Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol. 1994, 145 (2): 356-64.

Berg van den E, Hout van der AH, Oosterhuis JW: Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification. Int J Cancer. 1993, 55 (2): 223-7. 10.1002/ijc.2910550210.

Herbers J, Schullerus D, Chudek J: Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas. J Pathol. 1998, 184 (1): 58-62. 10.1002/(SICI)1096-9896(199801)184:1<58::AID-PATH987>3.0.CO;2-1.

Abrahams NA, MacLennan GT, Khoury JD: Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology. 2004, 45 (6): 593-602. 10.1111/j.1365-2559.2004.02003.x.

Chen YT, Tu JJ, Kao J, Zhou XK, Mazumdar M: Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma. Clin Cancer Res. 2005, 11 (18): 6558-66. 10.1158/1078-0432.CCR-05-0647.

Kwast Van der T, Perez-Ordonez B: Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm? [comment]. J Clin Pathol. 2007, 60 (6): 585-6. 10.1136/jcp.2006.044438.

Amin MB, Amin MB, Tamboli P: Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. [see comment]. Am J Surg Pathol. 2002, 26 (3): 281-91. 10.1097/00000478-200203000-00001. Verdorfer I, Hobisch A, Hittmair A, et al.: Cytogenetic characterization of 22 human renal cell tumors in relation to a histopathological classification. Cancer Genet Cytogenet 1999, 111(1): 61-70.

Dijkhuizen T, Berg van den E, Storkel S: Renal oncocytoma with t(5;12;11), der(1)1;8) and add(19): "true" oncocytoma or chromophobe adenoma?. Int J Cancer. 1997, 73 (4): 521-4. 10.1002/(SICI)1097-0215(19971114)73:4<521::AID-IJC11>3.0.CO;2-C.

Corless CL, Aburatani H, Fletcher JA, Housman DE, Amin MB, Weinberg DS: Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn Mol Pathol. 1996, 5 (1): 53-64. 10.1097/00019606-199603000-00009.

Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L: Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod Pathol. 2003, 16 (10): 1053-9. 10.1097/01.MP.0000090924.90762.94.

Gregori-Romero MA, Morell-Quadreny L, Llombart-Bosch A: A singular case of near-haploid stemline karyotype in a renal oncocytoma. Cancer Genet Cytogenet. 1996, 92 (1): 28-30. 10.1016/S0165-4608(96)00026-X.

Schmidt LS, Warren MB, Nickerson ML: Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet. 2001, 69 (4): 876-82. 10.1086/323744.

Nickerson ML, Warren MB, Toro JR: Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell. 2002, 2 (2): 157-64. 10.1016/S1535-6108(02)00104-6.

Linehan WM, Walther MM, Zbar B: The genetic basis of cancer of the kidney. J Urol. 2003, 170 (6 Pt 1): 2163-72. 10.1097/01.ju.0000096060.92397.ed.

da Silva NF, Gentle D, Hesson LB, Morton DG, Latif F, Maher ER: Analysis of the Birt-Hogg-Dube (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer. J Med Genet. 2003, 40 (11): 820-4. 10.1136/jmg.40.11.820.

Pavlovich CP, Walther MM, Eyler RA: Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol. 2002, 26 (12): 1542-52. 10.1097/00000478-200212000-00002.